Back
37 Capital Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
37
JJJ.CX
37 Capital
Last Price:
0.08
Seasonality Move:
37.16%
Buy
71
MDGL
Madrigal Pharmaceuticals
Last Price:
307.84
Seasonality Move:
31.67%
Sell
37
37 Capital (JJJ.CX)
is a Sell
Is 37 Capital a Buy, Sell or Hold?
- The current 37 Capital [JJJ.CX] share price is $0.08. The Score for JJJ.CX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- JJJ.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $259.34. The Score for MDGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JJJ.CX Stock Price Chart
What is 37 Capital's stock price today?
-
The 37 Capital share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JJJ.CX is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $259.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
JJJ.CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 27.84 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.08 - 0.1) | Sell |
Bollinger Bands (100): | (0.09 - 0.11) | Sell |
MDGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 74.74 | Buy |
Chaikin Money Flow: | 898979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (203.29 - 223.91) | Buy |
Bollinger Bands (100): | (221.8 - 277.54) | Buy |
JJJ.CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.08 | Sell |
20-day SMA: | 0.09 | Sell |
50-day SMA: | 0.1 | Sell |
200-day SMA: | 0.11 | Sell |
8-day EMA: | 0.08 | Sell |
20-day EMA: | 0.09 | Sell |
50-day EMA: | 0.09 | Sell |
200-day EMA: | 0.1 | Sell |
MDGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 216.22 | Buy |
20-day SMA: | 214.16 | Buy |
50-day SMA: | 227.04 | Buy |
200-day SMA: | 240.71 | Buy |
8-day EMA: | 223.2 | Buy |
20-day EMA: | 218.42 | Buy |
50-day EMA: | 226.38 | Buy |
200-day EMA: | 233.63 | Buy |
37 Capital Earnings Growth & JJJ.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.71 per share, a decrease next quarter of $0.00 per share, a decrease this year of $7.95 per share, and an increase next year of $9.71 per share.
37 Capital Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Madrigal Pharmaceuticals Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |